Cargando…
Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
Reinforcing defective tolerogenic processes slows progression of autoimmune (AI) diseases and has potential to promote drug-free disease remission. Previously, we reported that DNA nanoparticles (DNPs) and cyclic dinucleotides (CDNs) slow progression of experimental autoimmune encephalomyelitis (EAE...
Autores principales: | Lemos, Henrique, Mohamed, Eslam, Ou, Rong, McCardle, Caroline, Zheng, Xiaozhong, McGuire, Kris, Homer, Natalie Z. M., Mole, Damian J., Huang, Lei, Mellor, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311583/ https://www.ncbi.nlm.nih.gov/pubmed/32625215 http://dx.doi.org/10.3389/fimmu.2020.01256 |
Ejemplares similares
-
Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020) -
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019) -
Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors
por: Platten, Michael, et al.
Publicado: (2015) -
Two-Phase Evaluation of the Validity of a Measure for Self-Regulated Learning in Sport Practice
por: McCardle, Lindsay, et al.
Publicado: (2018) -
Diclofenac Identified as a Kynurenine 3-Monooxygenase
Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018)